Keywords: Guidelines; apolipoprotein B; cholesterol; dyslipidaemias; familial hypercholesterolaemia; high-density lipoproteins; lipoprotein remnants; lipoprotein(a); low-density lipoproteins; total cardiovascular risk; treatment (adherence); treatment (drugs); treatment (lifestyle); triglycerides; very low-density lipoproteins.